0

    539470

    SHREEGANES

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Shree Ganesh Biotech (India) L Share Price Today

    Investment Returns

    Over 1 Month 0.00% Over 3 Months -8.19% Over 6 Months -11.11% Over 1 Year -29.11%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Shree Ganesh Biotech (India) L fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 21.90
    • P/E Ratio (TTM) 56.00
    • Beta 0.40
    • Book Value / share 1.59
    • Return on equity 0.44%
    • EPS (TTM) 0.01
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.15
    info icon alternate text

    Shree Ganesh Biotech (India) L Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 2.12
    Operating Expense 2.55
    Net Profit -0.15
    Net Profit Margin (%) -7.07
    Earnings Per Share (EPS) 0.00
    EBITDA -0.15
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.70
    Operating Expense 0.75
    Net Profit 0.32
    Net Profit Margin (%) 45.71
    Earnings Per Share (EPS) 0.01
    EBITDA 0.32
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.77
    Operating Expense 1.16
    Net Profit 0.01
    Net Profit Margin (%) 1.29
    Earnings Per Share (EPS) 0.00
    EBITDA 0.01
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 1.38
    Operating Expense 1.47
    Net Profit 0.33
    Net Profit Margin (%) 23.91
    Earnings Per Share (EPS) 0.01
    EBITDA 0.33
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 3.01
    Operating Expense 4.42
    Net Profit -0.95
    Net Profit Margin (%) -31.56
    Earnings Per Share (EPS) -0.02
    EBITDA -0.95
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 4.97
    Operating Expense 5.93
    Net Profit 0.38
    Net Profit Margin (%) 7.64
    Earnings Per Share (EPS) 0.01
    EBITDA 0.51
    Effective Tax Rate (%) 27.45
    Particulars MAR 2025 (Values in Cr)
    Revenue 22.96
    Operating Expense 24.01
    Net Profit 0.28
    Net Profit Margin (%) 1.21
    Earnings Per Share (EPS) 0.01
    EBITDA 0.39
    Effective Tax Rate (%) 28.20
    Particulars MAR 2024 (Values in Cr)
    Revenue 20.28
    Operating Expense 20.48
    Net Profit 0.62
    Net Profit Margin (%) 3.05
    Earnings Per Share (EPS) 0.02
    EBITDA 0.85
    Effective Tax Rate (%) 27.05
    Particulars MAR 2023 (Values in Cr)
    Revenue 62.45
    Operating Expense 60.31
    Net Profit 2.04
    Net Profit Margin (%) 3.26
    Earnings Per Share (EPS) 0.05
    EBITDA 2.71
    Effective Tax Rate (%) 25.09
    Particulars MAR 2022 (Values in Cr)
    Revenue 72.64
    Operating Expense 69.20
    Net Profit 2.53
    Net Profit Margin (%) 3.48
    Earnings Per Share (EPS) 0.13
    EBITDA 3.50
    Effective Tax Rate (%) 27.71
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 1.59
    ROE % 0.44
    ROCE % 0.62
    Total Debt to Total Equity 0.00
    EBITDA Margin 1.70
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1.58
    ROE % 0.99
    ROCE % 1.36
    Total Debt to Total Equity 0.00
    EBITDA Margin 4.24
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 1.56
    ROE % 3.33
    ROCE % 4.43
    Total Debt to Total Equity 0.00
    EBITDA Margin 4.34
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 3.03
    ROE % 4.28
    ROCE % 5.92
    Total Debt to Total Equity 0.00
    EBITDA Margin 4.82
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 29.00
    ROE % 0.92
    ROCE % 1.23
    Total Debt to Total Equity 0.00
    EBITDA Margin 4.13
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 63.48
    Total Liabilities 63.48
    Total Equity 63.25
    Share Outstanding 39
    Price to Book Ratio 0.57
    Return on Assets (%) 0.43
    Return on Capital (%) 0.44
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.42
    Total Assets 73.62
    Total Liabilities 73.62
    Total Equity 62.97
    Share Outstanding 39
    Price to Book Ratio 0.66
    Return on Assets (%) 0.84
    Return on Capital (%) 0.99
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.48
    Total Assets 79.52
    Total Liabilities 79.52
    Total Equity 62.35
    Share Outstanding 39
    Price to Book Ratio 0.65
    Return on Assets (%) 2.56
    Return on Capital (%) 3.27
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 93.55
    Total Liabilities 93.55
    Total Equity 60.31
    Share Outstanding 19
    Price to Book Ratio 3.07
    Return on Assets (%) 2.69
    Return on Capital (%) 4.19
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 74.62
    Total Liabilities 74.62
    Total Equity 57.79
    Share Outstanding 1
    Price to Book Ratio 4.09
    Return on Assets (%) 0.42
    Return on Capital (%) 0.55
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.38
    Cash from Operations -10.21
    Cash from Investing 9.79
    Cash from Financing 0.00
    Net change in Cash -0.41
    Free Cash Flow -10.21
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.85
    Cash from Operations 10.15
    Cash from Investing -10.20
    Cash from Financing 0.00
    Net change in Cash -0.05
    Free Cash Flow 10.15
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.71
    Cash from Operations 11.21
    Cash from Investing -10.09
    Cash from Financing 0.00
    Net change in Cash 0.44
    Free Cash Flow 11.21
    Particulars MAR 2022 (Values in Cr)
    Net Income 3.49
    Cash from Operations 4.54
    Cash from Investing -3.36
    Cash from Financing -0.19
    Net change in Cash 0.01
    Free Cash Flow 4.54
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.42
    Cash from Operations 2.47
    Cash from Investing -2.35
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow 2.47
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 33.64 13.96 1.62 257.79 23.12 38.85
    BLISS GVS PHARMA LTD 454.10 36.50 4.03 4816.01 118.35 552.90
    CIPLA LTD. 1466.00 33.09 3.43 118430.12 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 465.55 21.78 3.36 1370.16 256.40 482.70
    GLAXOSMITHKLINE PHARMACEUTICAL 2609.65 45.94 19.49 44209.05 2088.00 3202.80
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 33.64 23.52 4.33 257.79 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 518.30 23.23 4.04 1498.44 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8090.05 105.72 23.17 20225.13 7630.00 9850.00
    BLISS GVS PHARMA LTD 454.10 49.09 4.16 4816.01 118.35 552.90

    Shree Ganesh Biotech (India) L shareholding pattern

    Holding
    98.57%
    1.42%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Shree Ganesh Biotech (India) L Technicals Summary

    0.55 -1.78 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 0.50
    • 26 Days 0.60
    • 10 Days 0.60
    • 50 Days 0.60
    • 12 Days 0.60
    • 100 Days 0.60
    • 20 Days 0.60
    • 200 Days 0.60
    0.55 PIVOT
    First Support 0.53 First Resistance 0.57 Second Support 0.51 Second Resistance 0.59 Third Support 0.49 Third Resistance 0.61
    RSI 50.61 ADX 16.89 MACD -0.01 Williams % R -50.00 Commodity Channel Index (CCI) -42.52
    Date 2026-07-30 Week 465702.00 Same Day 780328.00 Month 398698.00
    1 Year 0.40 3 Year 0.49
    Over 1 Month
    0.00% down
    Over 1 Year
    -29.11% down
    Over 3 Months
    -8.19% down
    Over 3 Years
    -18.38% down
    Over 6 Months
    -11.11% down
    Over 5 Years
    -38.37% down

    Shree Ganesh Biotech (India) L Corporate Actions

    Ex-Date Ex-Bonus Ratio
    28 Apr 2022 27 Apr 2022 1:1
    Ex-Date Old FV NEW FV Record Date
    10 Feb 2022 10.0 1.0 11 Feb 2022

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Shree Ganesh Biotech India Ltd?

    Answer Field

    Shree Ganesh Biotech India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.55 as on Jul 31 2026 03:30 PM.

    What is the Market Cap of Shree Ganesh Biotech India Ltd Share?

    Answer Field

    The market cap of Shree Ganesh Biotech India Ltd for NSE ₹ 0.00 & for BSE ₹ 21.90 as on Jul 31 2026 03:30 PM.

    What is the 52 Week High and Low of Shree Ganesh Biotech India Ltd?

    Answer Field

    The 52 Week High and Low of Shree Ganesh Biotech India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 0.81 and ₹ 0.52.

    What is 1 year return for Shree Ganesh Biotech India Ltd?

    Answer Field

    The 1 year returns on the stock has been -29.11%.

    What is the P/E Ratio of Shree Ganesh Biotech India Ltd Share?

    Answer Field

    As on Jul 31 2026 03:30 PM the price-to-earnings (PE) ratio for Shree Ganesh Biotech India Ltd share is 56.00.

    What is the PB ratio of Shree Ganesh Biotech India Ltd Share?

    Answer Field

    As on Jul 31 2026 03:30 PM, the price-to-book (PB) ratio for Shree Ganesh Biotech India Ltd share is 1.59.

    How to Buy Shree Ganesh Biotech India Ltd Share?

    Answer Field

    You can trade in Shree Ganesh Biotech India Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Shree Ganesh Biotech India Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Shree Ganesh Biotech India Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Shree Ganesh Biotech India Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |